-
Stocks to buy for short term: From SBI to Cipla— Ajit Mishra of Religare Broking recommends THESE 3 shares
19 Sep 2025 04:38 GMT
… ; said Mishra.
SBI technical chart
Cipla | LTP: ₹1,578.20 … 1,520
Mishra underscored that Cipla is consolidating after a … 1,600 was supported by healthy volume action, highlighting buyers’ … outlook," said Mishra.
Cipla technical chart
Ashok Leyland | …
-
HDFC Life, Sun Pharma, SBI Life, Eternal Share Price in Focus after Rally
19 Sep 2025 02:42 GMT
… ), SBI Life, Sun Pharma and Cipla were among major gainers on … launched Leqselvi, an anti-alopecia drug, in the US. The … company’s focus on specialty medicines, highlighting the importance of … trust.
Governance and Financial Health
The insurer also announced the …
-
Sensex Rallies 320 Points, Nifty Breaks 25,400 Barrier, Will Pharma Lead The Next Surge?
18 Sep 2025 11:25 GMT
… larger, more stable companies.
Pharma and Select Stocks Shine … Bright
Pharma stocks led the charge … HDFC Life, Sun Pharma, Infosys, and Cipla. These helped push the … in pharma suggests investors are favoring defensive or health‑oriented …
-
Nifty top gainers today, September 18: Eternal, HDFC Life, Sun Pharma, Cipla, Infosys and more
18 Sep 2025 10:54 GMT
…
Sun Pharmaceutical — closed at ₹1,648.5, up 1.8%
Cipla — closed …
-
Will legal troubles in the US weigh on India’s obesity drug boom?
17 Sep 2025 00:16 GMT
… for participants."
Sun Pharma, Dr Reddy’s, Cipla, Zydus Lifesciences Ltd … regulators face challenges around spurious medicines and cosmetic misuse.
The side … of a particular drug," said Biplab Lenin, partner (pharma, healthcare and life …
-
Pharma stocks slide as US headwinds hurt
16 Sep 2025 08:40 GMT
… weakening demand for Indian pharmaceutical (pharma) drugs in the US — … and Drug Administration observations, while Lupin and Cipla … oncology continue to show healthy demand, supporting overall … reducing reliance on Chinese biotech supply chains, could …
-
Nifty 50 top losers today, September 15: Cipla, Asian Paints, Mahindra & Mahindra, Shriram Finance, Dr. Reddy’s and more
15 Sep 2025 15:46 GMT
… top losers on September 12
Cipla closed 1.8% lower at … at ₹6,799.0
Sun Pharmaceutical closed 0.9% lower at …
-
Hepatitis C Treatment Market Poised for Rapid Growth: Innovations and Strategic Developments Driving Surge 2025-2032
19 Sep 2025 13:18 GMT
… growing government investments in healthcare infrastructure, and rising screening …
Genentech, Inc.
Kadmon Pharmaceuticals, LLC
Cipla Ltd
Mylan Laboratories Limited
… infections, technological advancements in drug therapies, and increased awareness …
-
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
19 Sep 2025 11:45 GMT
… global biotech company specializing in the development and manufacture of biosimilar medicines … from the Japanese Ministry of Health, Labor and Welfare. The biosimilars … Pharma (EEA, UK, Switzerland, Canada, Australia and New Zealand), Cipla/Cipla Gulf …
-
Pyelonephritis Treatment Market Poised for Breakthrough Growth with Rising Demand for Advanced Therapies 2025-2033
16 Sep 2025 13:22 GMT
… witnessing steady growth as healthcare providers and pharmaceutical companies focus on … Therapeutics, LLC.
Cipla.
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd. … While challenges such as rising drug resistance remain significant, opportunities in …